Transit Scientific

Executive Summary

Transit Scientific is a medical device company based in Salt Lake City, Utah, focused on innovative solutions for peripheral artery disease (PAD) and critical limb ischemia (CLI). The company has developed two FDA- and CE-Mark-approved devices: the XO Score Sheath Platform and the XO Cross micro and support catheters. The XO Score Sheath Platform is a versatile scoring sheath that can convert standard angioplasty balloons into scoring, cutting, and infusion vessel prep devices, enhancing the effectiveness of percutaneous interventions. The XO Cross catheters offer class-leading performance for crossing challenging lesions in PAD and CLI. With regulatory approvals in both the US and Europe, Transit Scientific is positioned to address significant unmet needs in vascular intervention, particularly in complex cases where traditional balloons and catheters may fail. The company's technology aims to improve procedural outcomes, reduce complications, and expand the treatable patient population. As a private company with a focused product portfolio, Transit Scientific is well-placed to capture market share in the growing endovascular device market, though detailed financial and operational data remain limited.

Upcoming Catalysts (preview)

• Q2 2027FDA clearance for next-generation XO Score Sheath with expanded indications70% success
• Q4 2026Publication of pivotal clinical trial data demonstrating superiority over conventional balloon angioplasty60% success
• Q3 2026Strategic partnership or distribution agreement for European market expansion50% success